Sirtex Medical (Sirtex Medical) Asset Impairment Charge : $0.00 Mil (TTM As of Jun. 2018)

View and export this data going back to 2015. Start your Free Trial

What is Sirtex Medical Asset Impairment Charge?

Sirtex Medical's Asset Impairment Charge for the six months ended in Jun. 2018 was $0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2018 was $0.00 Mil.

Sirtex Medical Asset Impairment Charge Historical Data

The historical data trend for Sirtex Medical's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sirtex Medical Asset Impairment Charge Chart

Sirtex Medical Annual Data

Trend

Jun09

Jun10

Jun11

Jun12

Jun13

Jun14

Jun15

Jun16

Jun17

Jun18

Asset Impairment Charge

Get a 7-Day Free Trial

Sirtex Medical Semi-Annual Data
	Dec08	Jun09	Dec09	Jun10	Dec10	Jun11	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18
Asset Impairment Charge	Get a 7-Day Free Trial															-	-	-	-	-

Sirtex Medical Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2018 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

Sirtex Medical Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Sirtex Medical's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Sirtex Medical (Sirtex Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sirtex Medical Ltd (GREY:SRXTY) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.sirtex.com

Sirtex Medical is an Australian oncology-focused medical device company with a novel embolic radiation therapy device, which is currently used as salvage therapy in the treatment of inoperable liver cancer. Sirtex's key product is SIR-Spheres microspheres, which utilise extremely small resin beads containing radioactive yttrium-90. SIR-Spheres are designed, manufactured, and distributed by Sirtex for approved markets in Asia-Pacific; Europe, Middle East, and Africa, or EMEA; and North America.

Sirtex Medical (Sirtex Medical) Headlines

No Headlines